Valley Cottage, New York, Oct. 25, 2017 -- With healthy CAGR of 5.5%, the global vascular access catheters market is likely to grow with an impressive growth rate during the projected period. The primary reasons for this remarkable growth is shift towards value-based healthcare model, increasing global healthcare spending and global manufacturer’s focus on emerging market. According to the new report “Vascular Access Catheters Market: Global Industry Analysis (2012 – 2016) and Opportunity Assessment (2017 – 2027) that is published by Future Market Insights, global vascular access catheters market to grow from US$ 2,365.3 Mn in 2017 to US$ 4,042.8 Mn by 2027 end. This represents CAGR of 5.5% over the projected period of 10-years. The global vascular access catheters market for represents absolute $ opportunity of US$ 118.9 Mn in 2018 over 2017 and incremental opportunity of US$ 1,677.5 Mn between 2017 and 2027.
Global Vascular Access Catheters Market: Drivers
Increased precision of PICC and CVC placement with tip location devices
Improved Reimbursement policies
Preference by surgeons, anaesthesiologists & interventional radiologists
Increasing number of diseases with PICC application
Distribution and collaboration agreement to increase product reach
Introduction of Innovative products
Product availability through appointing distributors
Increasing forward integration
Introduction of new PICC having anti-thrombogenic property
Radiopaque catheter material or marking
Global Market Research Report Overview on Vascular Access Catheters @ https://www.futuremarketinsights.com/reports/vascular-access-catheters-market
Global Vascular Access Catheters Market: Forecast by Product
On the basis of product type, the global vascular access catheters market is segmented into CVC Catheters, Implantable Port, Dialysis Catheters and PICC Catheters. CVC catheters dominated the global market in 2016, and is expected to continue to do so. Also, increasing approvals for new products in the hemodialysis and peritoneal dialysis segment would further increase the adoption.
Global Vascular Access Catheters Market: Forecast by End Use
By end use the global market for vascular access catheters market is segmented into hospitals, ambulatory surgical centres and specialty clinics and others. Hospital is expected to be the most lucrative among all end users of vascular access catheters products, with attractiveness index of 2.7, while specialty clinics and others are expected to be the least attractive end users of vascular access catheters, with market share index of 0.8.
View Report Table of Contents, Figures, and Tables @ https://www.futuremarketinsights.com/reports/vascular-access-catheters-market/toc
Global Vascular Access Catheters Market: Forecast by Design
Design segment consists of single lumen, double lumen, and multiple lumen. Double Lumen, dominated the vascular access catheters market in revenue terms in 2016, and the trend is projected to continue throughout the forecast period. Double lumen catheters is expected to be the most lucrative among property segment, with attractiveness index of 2.1.
Global Vascular Access Catheters Market: Forecast by Property
The property segment of the global vascular access catheters market includes antimicrobial catheter and non-anti-microbial catheter. Non Anti-microbial catheter, dominated the vascular access catheters market in revenue terms in 2016, and the trend is projected to continue throughout the forecast period. Non Anti-microbial Catheter is expected to be the most lucrative among Property segment, with attractiveness index of 1.5.
A sample of this report is available upon request@ https://www.futuremarketinsights.com/reports/sample/rep-gb-5327
Global Vascular Access Catheters Market: Forecast by Region
This report has covered seven regions namely, North America, Latin America, Eastern Europe, Western Europe, APEJ, Japan and MEA. North America vascular access catheters market accounted for largest revenue share of 44.6% in 2016. Western Europe is expected to experience highest CAGR of 5.8% over 2017–2027, primarily due to increase in chronic kidney dialysis & cancer. Also rising healthcare reach in untapped markets may spur revenue growth during the forecast period.
Global Vascular Access Catheters Market: Key Players
Some of the key players operating in the global vascular access catheters market are Angio Dynamics, C.R. Bard, Teleflex Incorporated, B. Braun Melsungen AG, Kimal Healthcare, Comed B.V., Medtronic Plc, Smiths Medical, Vygon (UK) Ltd, Becton, Dickinson and Company, Argon Medical Devices, Inc., Boston Scientific Corporation, Cook Medical Incorporated and Fresenius Kabi AG.
616 Corporate Way, Suite 2-9018, Valley Cottage, NY 10989, United States T: +1-347-918-3531 F: +1-845-579-5705 T (UK): +44(0)20-7692-8790 Sales: [email protected] Website: http://www.futuremarketinsights.com


xAI Cash Burn Highlights the High Cost of Competing in Generative AI
GM Takes $6 Billion EV Write-Down as Electric Vehicle Demand Slows in the U.S.
Trump Calls for 10% Credit Card Interest Rate Cap Starting 2026
Elon Musk Says X Will Open-Source Its Algorithm Amid EU Scrutiny
FCC Exempts Select Foreign-Made Drones From U.S. Import Ban Until 2026
Boeing 737 MAX 10 Advances in FAA Testing as Certification Delays Continue
Hanwha Ocean Shares Rise on Plans to Expand U.S. Shipbuilding Capacity
UBS Upgrades L’Oréal to Buy, Sees Strong Sales Momentum and 20% Upside
Trump Pushes $100 Billion U.S. Oil Investment Plan for Venezuela After Maduro Seizure
Johnson & Johnson Secures Tariff Exemption by Agreeing to Lower Drug Prices in the U.S.
Stellantis to End Plug-In Hybrid Sales in the U.S. as Demand Shifts Toward Traditional Hybrids
Chevron Sees Path to Boost Venezuela Oil Output by 50% After Trump Administration Talks
Nvidia Appoints Former Google Executive Alison Wagonfeld as First Chief Marketing Officer
China’s AI Sector Pushes to Close U.S. Tech Gap Amid Chipmaking Challenges
Ford Targets Level 3 Autonomous Driving by 2028 with New EV Platform and AI Innovations
AustralianSuper Backs BlueScope Steel’s Rejection of $9 Billion Takeover Bid
Aktis Oncology Prices Upsized IPO at $18, Raising $318 Million in Major Biotech Debut 



